• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    5/15/24 1:38:38 PM ET
    $AEMD
    $AMC
    $ARQT
    $AWIN
    Medical/Dental Instruments
    Health Care
    Movies/Entertainment
    Consumer Discretionary
    Get the next $AEMD alert in real time by email

    Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday's session after the company reported first-quarter financial results.

    Bolt Biotherapeutics posted a GAAP loss of 28 cents per share on sales of $5.30 million, according to data from Benzinga Pro.

    Also, Guggenheim analyst Michael Schmidt downgraded Bolt Biotherapeutics from Buy to Neutral, while Stifel analyst Stephen Willey downgraded the stock from Buy to Hold and lowered the price target from $6 to $1.5.

    Bolt Biotherapeutics shares dipped 34.4% to $0.8652 on Wednesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • AERWINS Technologies Inc. (NASDAQ:AWIN) shares surged 201% to $8.16.
    • Sintx Technologies, Inc. (NASDAQ:SINT) jumped 169% to $0.1449 after jumping over 41% on Tuesday. SINTX Technologies recently posted downbeat quarterly results.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) jumped 87% to $0.5336 after jumping around 368% on Tuesday.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) climbed 53.2% to $6.54 following first-quarter results.
    • iPower Inc. (NASDAQ:IPW) gained 53% to $1.36 after the company reported better-than-expected third-quarter financial results.
    • Selina Hospitality PLC (NASDAQ:SLNA) jumped 51% to $0.0850.
    • Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) shares gained 41% to $0.0627 after surging 7% on Tuesday.
    • Complete Solaria, Inc. (NASDAQ:CSLR) gained 30.6% to $0.90. Complete Solaria signed a term sheet to eliminate Carlyle debt.
    • OptimizeRx Corporation (NASDAQ:OPRX) jumped 24% to $13.03 following upbeat quarterly results.
    • Blue Star Foods Corp. (NASDAQ:BSFC) rose 23% to $0.0686.
    • monday.com Ltd. (NASDAQ:MNDY) jumped 21.5% to $220.93 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.
    • Telos Corporation (NASDAQ:TLS) gained 21.4% to $3.85.
    • BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) rose 20% to $6.44.
    • Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) rose 16.5% to $9.47 after the company reported better-than-expected first-quarter financial results.
    • Dolphin Entertainment, Inc. (NASDAQ:DLPN) rose 15.4% to $1.2999 after the company reported a year-over-year increase in first-quarter financial results.
    • Codere Online Luxembourg, S.A. (NASDAQ:CDRO) jumped 14.3% to $7.98 following first-quarter results.
    • Nutriband Inc. (NASDAQ:NTRB) gained 13.5% to $4.34.
    • Riskified Ltd. (NYSE:RSKD) jumped 12.8% to $6.05 following upbeat results.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) gained 12.8% to $12.66 following first-quarter results.
    • Jeffs’ Brands Ltd (NASDAQ:JFBR) jumped 12% to $0.2530.
    • B&G Foods, Inc. (NYSE:BGS) rose 11.5% to $9.53.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares rose 11.2% to $0.0529.
    • Pineapple Energy Inc. (NASDAQ:PEGY) gained 8.1% to $0.0637 after adding around 12% on Tuesday.
    • Dell Technologies Inc. (NYSE:DELL) rose 6% to $142.18 after Morgan Stanley maintained an Overweight rating on the stock and raised its price target from $128 to $152.

    Losers

    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares fell 63.9% to $0.8199 after the company reported pricing of $2.25m public offering.
    • Yield10 Bioscience, Inc. (NASDAQ:YTEN) fell 49.4% to $2.66 after the company reported delisting from the Nasdaq.
    • Aethlon Medical, Inc. (NASDAQ:AEMD) fell 45.8% to $0.4604 after the company announced pricing of $4.7 million public offering.
    • Pixelworks, Inc. (NASDAQ:PXLW) dipped 40.2% to $1.1186 after the company issued soft second-quarter guidance.
    • GameStop Corp. (NYSE:GME) shares fell 31.9% to $33.22 following a 60% surge on Tuesday.
    • Koss Corporation (NASDAQ:KOSS) dipped 31% to $4.24.
    • VirTra, Inc. (NASDAQ:VTSI) shares fell 30% to $11.49 after the company reported worse-than-expected first-quarter financial results.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) dipped 30.3% to $2.25.
    • SunPower Corporation (NASDAQ:SPWR) shares fell 29.6% to $3.0896. Wolfe Research analyst Steve Fleishman downgraded SunPower from Peer Perform to Underperform.
    • Intrusion Inc. (NASDAQ:INTZ) shares declined 28.7% to $1.84 after the company reported downbeat first-quarter sales.
    • DLocal Limited (NASDAQ:DLO) fell 27.5% to $9.84 after the company reported weaker-than-expected first-quarter earnings and said there is a greater likelihood of coming in towards the lower end of its guidance range.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) fell 26.3% to $5.04 after jumping 32% on Tuesday.
    • Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) declined 25% to $2.7550.
    • The Oncology Institute, Inc. (NASDAQ:TOI) fell 24.4% to $0.6798 following weak quarterly results.
    • Cheetah Net Supply Chain Service Inc. (NASDAQ:CTNT) shares fell 23.2% to $4.92 after jumping 442% on Tuesday. The company priced a follow-on offering for gross proceeds of $8.19 million.
    • Nortech Systems Incorporated (NASDAQ:NSYS) fell 21.1% to $11.97. Nortech Systems is expected to hold a conference call on Thursday, May 16, to discuss the company’s first quarter financial results.
    • Virgin Galactic Holdings, Inc. (NASDAQ:SPCE) fell 16.5% to $1.06.
    • Novavax, Inc. (NASDAQ:NVAX) declined 12.5% to $11.80.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) declined 12.1% to $6.74. Pulse Biosciences named Burke T. Barrett as President and Chief Executive Officer.
    • iRobot Corporation (NASDAQ:IRBT) fell 11.8% to $11.24.
    • BlackBerry Limited (NYSE:BB) fell 10.2% to $3.11.
    • Sunnova Energy International Inc. (NYSE:NOVA) fell 9.9% to $4.8000.
    • NIO Inc. (NYSE:NIO) dipped 9.5% to $5.24. New reports indicate the company on Wednesday launched its first vehicle under its new Onvo brand.
    • Rivian Automotive, Inc. (NASDAQ:RIVN) fell 8.7% to $10.22.
    • Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) shares fell 8.3% to $15.30. Brazil's President Luiz Inacio Lula da Silva fired Jean Paul Prates, the CEO of Petrobras, following a dispute over dividend.

    Now Read This: Jim Cramer: This Industrial Company Is ‘Absolutely Terrific’, Recommends Buying Modine Manufacturing

    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEMD
    $AMC
    $ARQT
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Petroleo Brasileiro S.A. Petrobras
    $PBR
    3/13/2026$19.00Buy → Hold
    Jefferies
    NIO Inc.
    $NIO
    3/13/2026$6.80Hold → Buy
    HSBC Securities
    NIO Inc.
    $NIO
    3/11/2026$6.60Neutral → Buy
    Nomura
    Rivian Automotive Inc.
    $RIVN
    3/10/2026$20.00Hold → Buy
    TD Cowen
    Rivian Automotive Inc.
    $RIVN
    3/4/2026$14.00Underperform
    BofA Securities
    monday.com Ltd.
    $MNDY
    2/23/2026$80.00Buy → Hold
    Jefferies
    BioCryst Pharmaceuticals Inc.
    $BCRX
    2/18/2026$17.00Outperform
    Evercore ISI
    Rivian Automotive Inc.
    $RIVN
    2/17/2026$14.00Neutral → Underperform
    DA Davidson
    More analyst ratings

    $AEMD
    $AMC
    $ARQT
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Adasczik Michael

    4 - B&G Foods, Inc. (0001278027) (Issuer)

    3/27/26 6:15:40 PM ET
    $BGS
    Packaged Foods
    Consumer Staples

    SEC Form 4 filed by Hart Eric H

    4 - B&G Foods, Inc. (0001278027) (Issuer)

    3/27/26 6:13:48 PM ET
    $BGS
    Packaged Foods
    Consumer Staples

    SEC Form 4 filed by Keller Kenneth C Jr

    4 - B&G Foods, Inc. (0001278027) (Issuer)

    3/27/26 6:12:00 PM ET
    $BGS
    Packaged Foods
    Consumer Staples

    $AEMD
    $AMC
    $ARQT
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MicroCloud Hologram Inc. Reports 39.1% Increase in Total Revenue for Fiscal 2025

    SHENZHEN, China, March 27, 2026 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ:HOLO) ("MicroCloud" or the "Company") today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the "SEC"). MicroCloud is dedicated to the research, development, and application of holographic technology, striving to offer leading holographic technology services to customers. The Company delivered strong operating and financial performance in 2025, highlighted by robust revenue growth, continued net loss improvement and a substantial strengthening of liquidity and capital resources.Financial Highlights for Fisca

    3/27/26 1:47:00 PM ET
    $HOLO
    Computer Software: Programming Data Processing
    Technology

    Jeffs' Brands: KeepZone AI Enters into Agent Agreement with Skyline Software Systems to Offer 3D Geospatial Visualization Solutions to Global Security Markets

    Tel Aviv, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd ("Jeffs' Brands" or the "Company") (NASDAQ:JFBR, JFBRW)), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence ("AI") – driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. ("KeepZone"), has entered into a non-exclusive Agent Agreement (the "Agreement") with Skyline Software Systems, Inc. ("Skyline"), a  leading provider of 3D geospatial visualization software and services. Under the terms of the Agreement, KeepZone is authorized to market, sell, and distribute Skyline's proprieta

    3/27/26 8:55:00 AM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    Nortech Systems Reports Fourth Quarter Results

    MINNEAPOLIS, March 26, 2026 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (NASDAQ:NSYS) ("Nortech" or the "Company"), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, reported financial results for the fourth quarter ended December 31, 2025. 2025 Q4 Highlights:  ●Net sales of $30.3 million in Q4 2025 vs. $28.6 million in Q4 2024 ●Net income of $897 thousand, or $0.32 per basic share in Q4 2025 vs. $(1,478) thousand, or $(0.54) per basic share in Q4 2024 ●Adjusted earnings before interest, taxes, depreciation, and amortization (

    3/26/26 5:02:00 PM ET
    $NSYS
    Industrial Machinery/Components
    Technology

    $AEMD
    $AMC
    $ARQT
    $AWIN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for ZORYVE issued to ARCUTIS BIOTHERAPEUTICS INC

    Submission status for ARCUTIS BIOTHERAPEUTICS INC's drug ZORYVE (ORIG-1) with active ingredient ROFLUMILAST has changed to 'Approval' on 12/15/2023. Application Category: NDA, Application Number: 217242, Application Classification: Type 3 - New Dosage Form

    12/19/23 3:40:08 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $AMC
    $ARQT
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Petrobras downgraded by Jefferies with a new price target

    Jefferies downgraded Petrobras from Buy to Hold and set a new price target of $19.00

    3/13/26 9:34:06 AM ET
    $PBR
    Oil & Gas Production
    Energy

    NIO upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded NIO from Hold to Buy and set a new price target of $6.80

    3/13/26 8:42:10 AM ET
    $NIO
    Auto Manufacturing
    Industrials

    NIO upgraded by Nomura with a new price target

    Nomura upgraded NIO from Neutral to Buy and set a new price target of $6.60

    3/11/26 8:29:36 AM ET
    $NIO
    Auto Manufacturing
    Industrials

    $AEMD
    $AMC
    $ARQT
    $AWIN
    SEC Filings

    View All

    Pulse Biosciences Inc filed SEC Form 8-K: Leadership Update

    8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    3/27/26 4:32:55 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form DEFA14A filed by Telos Corporation

    DEFA14A - TELOS CORP (0000320121) (Filer)

    3/27/26 4:03:35 PM ET
    $TLS
    EDP Services
    Technology

    SEC Form DEF 14A filed by Telos Corporation

    DEF 14A - TELOS CORP (0000320121) (Filer)

    3/27/26 4:02:31 PM ET
    $TLS
    EDP Services
    Technology

    $AEMD
    $AMC
    $ARQT
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Chernett Jorey bought $1,225,101 worth of shares (398,985 units at $3.07), increasing direct ownership by 4% to 10,251,929 units (SEC Form 4)

    4 - Oncology Institute, Inc. (0001799191) (Issuer)

    3/17/26 7:40:00 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Chief Executive Officer O'Dowd William Iv bought $4,929 worth of shares (3,100 units at $1.59), increasing direct ownership by 0.69% to 450,090 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    3/16/26 7:33:14 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Director Lyons Christopher Michael bought $24,092 worth of shares (8,292 units at $2.91) (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    3/10/26 9:00:18 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $AEMD
    $AMC
    $ARQT
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cheetah Net Supply Chain Service Inc.

    SC 13G/A - CHEETAH NET SUPPLY CHAIN SERVICE INC. (0001951667) (Subject)

    12/12/24 4:29:36 PM ET
    $CTNT
    Motor Vehicles
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by OptimizeRx Corporation

    SC 13G/A - OptimizeRx Corp (0001448431) (Subject)

    12/6/24 4:26:03 PM ET
    $OPRX
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEMD
    $AMC
    $ARQT
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    Virgin Galactic Appoints Megan Prichard as Chief Growth Officer

    Veteran technology leader and former Uber executive to drive revenue growth, market expansion and customer acquisition for human spaceflight and research missions Virgin Galactic Holdings, Inc. (NYSE:SPCE) ("Virgin Galactic" or the "Company"), a leader in commercial spaceflight and advanced aerospace technology, today announced the appointment of Megan Prichard as its new Chief Growth Officer (CGO), effective April 6. In this newly established role, Prichard will lead the Company's integrated growth and revenue strategy across all business lines while strengthening Virgin Galactic's position as the premier platform for suborbital spaceflight expeditions and scientific research. Prichard

    3/23/26 4:05:00 PM ET
    $BL
    $SPCE
    Computer Software: Prepackaged Software
    Technology
    Transportation Services
    Consumer Discretionary

    SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

    Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced biomaterials company focused on developing silicon nitride technologies for medical applications, today provided a corporate business update highlighting recent clinical, operational, and leadership milestones that the Company believes position it for commercial expansion and future revenue growth. The update follows a series of key developments, including the successful completion of the first human surgical procedure us

    3/23/26 9:15:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Riskified Announces Board Changes and Appoints Dr. Samer Haj-Yehia to Board of Directors

    Riskified (NYSE:RSKD), a leader in ecommerce fraud and risk intelligence, today announced the appointment of Dr. Samer Haj-Yehia to its Board of Directors and as a member of the Audit Committee, effective March 19, 2026. The company also announced that Aaron Mankovski resigned from the Board after nearly a decade of service, as of March 17, 2026. "On behalf of the entire Board and the Riskified team, I want to express my gratitude to Aaron Mankovski for his guidance and partnership since our early days," said Eido Gal, Chairman and CEO of Riskified. "Aaron's vision and support were instrumental in our journey from a startup to a public company and I am thankful for his contributions." G

    3/23/26 8:00:00 AM ET
    $LMND
    $RSKD
    Property-Casualty Insurers
    Finance
    Real Estate

    $AEMD
    $AMC
    $ARQT
    $AWIN
    Financials

    Live finance-specific insights

    View All

    Nortech Systems Reports Fourth Quarter Results

    MINNEAPOLIS, March 26, 2026 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (NASDAQ:NSYS) ("Nortech" or the "Company"), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, reported financial results for the fourth quarter ended December 31, 2025. 2025 Q4 Highlights:  ●Net sales of $30.3 million in Q4 2025 vs. $28.6 million in Q4 2024 ●Net income of $897 thousand, or $0.32 per basic share in Q4 2025 vs. $(1,478) thousand, or $(0.54) per basic share in Q4 2024 ●Adjusted earnings before interest, taxes, depreciation, and amortization (

    3/26/26 5:02:00 PM ET
    $NSYS
    Industrial Machinery/Components
    Technology

    VirTra Reports Fourth Quarter and Full Year 2025 Financial Results

    CHANDLER, Ariz., March 26, 2026 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) ("VirTra" or the "Company"), a global provider of judgmental use-of-force and firearms training simulators, reported results for the fourth quarter and full year ended December 31, 2025. The financial statements are available on VirTra's website and here. Fourth Quarter 2025 and Recent Operational Highlights Bookings totaled $7.3 million in Q4 2025, bringing total bookings for 2025 to $26.7 million.Total backlog was $25.6 million at December 31, 2025.Demonstrated its next-generation Drone Defense Training System for corrections professionals as agencies prepare officers to detect, track, and respond to unauth

    3/26/26 4:05:00 PM ET
    $VTSI
    Miscellaneous manufacturing industries
    Consumer Discretionary

    GameStop Reports Fourth Quarter and Fiscal Year 2025 Results

    GameStop Corp. (NYSE:GME) ("GameStop" or the "Company") today released financial results for the fourth quarter and fiscal year ended January 31, 2026. The Company's consolidated financial statements, including GAAP and non-GAAP results, are below. The Company's Form 10-K and supplemental information can be found at https://investor.gamestop.com. FOURTH QUARTER OVERVIEW Net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter. Selling, general and administrative ("SG&A") expenses were $241.5 million for the fourth quarter, compared to $282.5 million in the prior year's fourth quarter. Operating income was $135.2 million f

    3/24/26 4:02:00 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary